For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Beth Israel Deaconess Medical Center, Inc.

USPTO Granted Patents = 517

CIPO Patents = 14

EPO Patents = 85

Trademarks = 12

Forward Citations = 7,078

Loading Chart...

Loading Chart...

692 inventors (with patents filed for the assignee):

Dan H Barouch (37 out of 38 patents)

John V Frangioni (23 out of 35 patents)

Reza Nezafat (20 out of 23 patents)

4. Vikas P Sukhatme (19 out of 33 patents)

5. S Ananth Karumanchi (19 out of 19 patents)

6. Kun Ping Lu (17 out of 25 patents)

7. Terry Barton Strom (17 out of 35 patents)

8. David C Alsop (16 out of 21 patents)

9. Xiao Zhen Zhou (15 out of 15 patents)

10. Bette T Korber (14 out of 31 patents)

11. Gerald B Pier (14 out of 38 patents)

12. Lisa Cavacini (14 out of 17 patents)

13. Marshall R Posner (14 out of 14 patents)

14. William M Fischer (13 out of 17 patents)

15. Barton F Haynes (12 out of 81 patents)

Core Competencies:

Diabetic Wound Healing

Cytokine Storm

Electromyography

Antibody Therapies

Cancer Immunotherapy

Non-Alcoholic Steatohepatitis

Cardiovascular Outcomes

Mitochondria Therapy

Thrombotic Events

Neoplastic Lesions

Micro-RNA

Optical Microscopy

517 patents: Sort by Forward Citations

1. 12496213 - Thermally activated pessary (2025-12-16),

2. 12485202 - Shape memory adhesive materials for diabetic wound healing (2025-12-02),

3. 12485107 - Methods for the prevention or treatment of cytokine storm (2025-12-02),

4. 12471824 - Needle impedance electromyography and electrical impedance imaging for enhanced muscle diagnostics (2025-11-18),

5. 12459989 - Antibody therapies for human immunodeficiency virus (HIV) (2025-11-04),

6. 12459938 - ORAI channel inhibitors (2025-11-04),

7. 12428410 - Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy (2025-09-30),

8. 12403123 - Method for treating sickle cell disease using quercetin-containing compositions (2025-09-02),

9. 12396996 - Compounds, pharmaceutical compositions, and methods of their use in reversing cancer chemoresistance (2025-08-26),

10. 12372530 - Markers for the diagnosis and treatment of non-alcoholic steatohepatitis (NASH) and advanced liver fibrosis (2025-07-29),

11. 12371507 - CDCP1 antibodies and antibody drug conjugates (2025-07-29),

12. 12364750 - Conserved region T cell vaccines for coronavirus and methods of use (2025-07-22),

13. 12357278 - Echocardiography deep learning and cardiovascular outcomes (2025-07-15),

14. 12312382 - Recombinant adenoviruses and uses thereof (2025-05-27),

15. 12307206 - Clinical documentation system (2025-05-20),

Beth Israel Deaconess Medical Center (BIDMC) is a world-class teaching hospital affiliated with Harvard Medical School. It is located in Boston, Massachusetts, USA. BIDMC provides patient care, conducts leading-edge research, and trains the next generation of medical professionals. The hospital offers a wide range of medical services, including primary care, advanced specialty care, and emergency services. BIDMC is committed to delivering compassionate and exceptional healthcare to its patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

517 Patents

#12 in Boston, MA

#57 in Massachusetts

#912 in US

#1,826 in the World

Boston, MA, United States of America

Beth Israel Deaconess Medical Center, Inc.

Forward Citations = 7,078

692 inventors:

Dan H Barouch (37 out of 38 patents)

John V Frangioni (23 out of 35 patents)

Reza Nezafat (20 out of 23 patents)

4. Vikas P Sukhatme (19 out of 33 patents)

5. S Ananth Karumanchi (19 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…